Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero
Ralley Prentice(St Vincent's Hospital Melbourne), Sally Bell(University of Glasgow), Ian C. Lawrance(The University of Western Australia), Sara Vogrin(The University of Melbourne), Emma Flanagan(The University of Melbourne), Sam Rosella(Alfred Health), Emily K. Wright(Brigham and Women's Hospital), Rimma Goldberg(Medical Research Council), Katerina Kiburg(Centre for Eye Research Australia), Jakob Begun(Translational Research Institute), Yoon‐Kyo An(Mater Hospital), Michael A. Kamm(The University of Melbourne), Miles Sparrow(Alfred Health), Megan Burns(Monash Health), Alyson L Ross(St Vincent's Hospital Melbourne), Lani Prideaux(Monash Health), Ourania Rosella(Alfred Health)
Cited by 23
Related Papers
Myths and Misconceptions About Chronic Constipation
|The American Journal of Gastroenterology|2005|619
AGA technical review on anorectal testing techniques
|Gastroenterology|1999|461
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
|Journal of Crohn s and Colitis|2017|425
Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
|Gastroenterology|2006|352
A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation
|Alimentary Pharmacology & Therapeutics|2008|272